Be part of the Pharmaceutical Industry’s Global Think Tank on SPCs and Patent Extensions
This year’s C5’s Pharma Patent Term Extensions Forum arrives at a critical time for the pharmaceutical industry. Overarching developments from the Teva U.K. decision (C-121/17) to the SPC Manufacturing Waiver and the most recent CJEU Abraxis decision are expected to have a significant impact on the future of the pharmaceutical and biotech industries.
Be part of an exclusive gathering of leading in-house IP counsel, patent attorneys, representatives from multi-jurisdiction patent offices and policy authorities from around the globe who will share their insights on the complexities of SPCs and other types of patent extensions. They will provide you with comprehensive knowledge to ensure that you are leading the way in patent protection for your company and clients.
Head of Patent Affairs
Midas Pharma
Head Patents – IP Product Strategy
Sandoz
Policy Officer
European Commission
Head of SPC Working Group
German Patent & Trade Mark Office
International Legal Affairs
European Patent Office
Patent Examiner
Netherlands Patent Office
Head of Patent and Utility Model Department
Instituto Nacional da Propriedade Industrial (INPI)
Legal Expert – Europe and International
INPI (France Patent Office)
2019 Topics will include:
- Supplementary Protection Certificate Regulation Article 3(a) and (d): Exploring questions of derivatives and the scope of SPC legitimacy.
- The Practical aftermath of the Teva U.K. decision (C-121/17)
- European Commission amendments to the SPC regulation for medicinal products (EC) 469/2009 of 6 May 2009)
- The Imminent arrival of SPC / PTE in China
- SPC eligibility for new formulations of old drugs in Europe in light of the CJEU decision on Art. 3(d) in Abraxis
- Post Brexit Effect on the legalities and enforcement of SPC
- Developments in the U.S affecting patent term extension (PTE) and patent term adjustment (PTA)
THE CONFERENCE WILL PROVIDE INSIGHTS ON ALL THIS AND OTHER KEY CHALLENGES!
THIS IS AN ESSENTIAL EVENT FOR
- Global Patent Attorney
- Patent Examiner
- Head of Patent
- Chief Patent Counsel
- VP Patent Law
- Patent & Legal Managers
- Legal Director
- Senior Counsel, Global Patents
- Head of Intellectual Property Rights
- Head of Patent Strategies & Litigation
- Head of Legal
- IP and Patent Extensions
OUR PRIOR DELEGATES SAY IT BEST:
“I was pleasantly surprised by the content. There was less repetition than previous events; the general quality and variety of speakers was good and I certainly learned something.” Robin Ellis Head of IP, Sandoz
“Good conference with international coverage from Europe as well as the rest of the world. Good and interesting speakers.” Dorte Petersen, Senior Examiner, The Danish Patent and Trademark Office
“A great and info-rich conference.” Ronnie Benshafrut Patent Attorney, Reinhold Cohn and Partners